News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
17,689 Results
Type
Article (577)
Company Profile (3)
Press Release (17109)
Section
Business (10203)
Career Advice (8)
Deals (1582)
Drug Delivery (1)
Drug Development (1305)
Employer Resources (2)
FDA (215)
Job Trends (567)
News (12422)
Policy (437)
Tag
Academia (41)
Allergies (5)
Alliances (603)
ALS (1)
Alzheimer's disease (27)
Antibody-drug conjugate (ADC) (7)
Approvals (215)
Artificial intelligence (4)
Autoimmune disease (1)
Automation (1)
Bankruptcy (6)
Best Places to Work (514)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (7)
Breast cancer (9)
Cancer (82)
Cardiovascular disease (4)
Career advice (9)
CAR-T (4)
Cell therapy (10)
Cervical cancer (1)
Clinical research (1161)
Collaboration (18)
Compensation (9)
COVID-19 (43)
CRISPR (1)
C-suite (4)
Cystic fibrosis (3)
Data (89)
Depression (2)
Diabetes (7)
Diagnostics (206)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (3)
Drug pricing (1)
Duchenne muscular dystrophy (9)
Earnings (9639)
Editorial (1)
Employer resources (2)
Events (1009)
Executive appointments (11)
FDA (285)
Funding (32)
Gene editing (3)
Generative AI (1)
Gene therapy (8)
GLP-1 (22)
Government (44)
Guidances (44)
Healthcare (616)
HIV (1)
IgA nephropathy (1)
Immunology and inflammation (4)
Immuno-oncology (1)
Indications (3)
Infectious disease (52)
Inflammatory bowel disease (1)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (4)
Interviews (1)
IPO (1198)
IRA (1)
Job creations (97)
Job search strategy (6)
Labor market (1)
Layoffs (11)
Legal (68)
Liver cancer (4)
Lung cancer (11)
Lymphoma (7)
Manufacturing (5)
MASH (2)
Medical device (592)
Medtech (592)
Mergers & acquisitions (404)
Metabolic disorders (21)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (2)
Neuroscience (39)
NextGen: Class of 2025 (160)
Non-profit (67)
Now hiring (1)
Obesity (13)
Opinion (7)
Ovarian cancer (2)
Pancreatic cancer (3)
Parkinson's disease (4)
Patents (6)
Patient recruitment (1)
Peanut (4)
People (456)
Pharmacy benefit managers (1)
Phase I (252)
Phase II (479)
Phase III (525)
Pipeline (213)
Policy (2)
Postmarket research (44)
Preclinical (90)
Prostate cancer (4)
Radiopharmaceuticals (9)
Rare diseases (12)
Real estate (82)
Recruiting (1)
Regulatory (372)
Reports (1)
Research institute (40)
Resumes & cover letters (2)
Rett syndrome (1)
RNA editing (1)
RSV (4)
Schizophrenia (1)
Series A (6)
Series B (6)
Service/supplier (1)
Sickle cell disease (2)
Startups (54)
Stomach cancer (1)
Vaccines (24)
Venture capital (1)
Weight loss (9)
Women's health (2)
Worklife (1)
Date
Today (2)
Last 7 days (9)
Last 30 days (47)
Last 365 days (1316)
2025 (660)
2024 (1527)
2023 (1743)
2022 (1775)
2021 (1862)
2020 (1649)
2019 (1204)
2018 (1005)
2017 (845)
2016 (511)
2015 (706)
2014 (472)
2013 (317)
2012 (346)
2011 (385)
2010 (411)
Location
Africa (6)
Alabama (1)
Arizona (7)
Asia (939)
Australia (68)
California (319)
Canada (75)
China (20)
Colorado (16)
Connecticut (15)
Delaware (12)
Europe (2434)
Florida (36)
Georgia (16)
Illinois (28)
India (1)
Indiana (13)
Japan (3)
Kansas (3)
Kentucky (1)
Louisiana (3)
Maine (27)
Maryland (50)
Massachusetts (203)
Michigan (8)
Minnesota (15)
Missouri (2)
Montana (1)
Nevada (1)
New Hampshire (8)
New Jersey (86)
New York (137)
North Carolina (42)
Northern California (151)
Ohio (4)
Pennsylvania (83)
South America (25)
Southern California (139)
Tennessee (8)
Texas (30)
United States (1168)
Utah (6)
Virginia (2)
Washington D.C. (2)
Washington State (19)
Wisconsin (1)
17,689 Results for "175".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vor Bio Announces $175 Million Private Placement
June 26, 2025
·
3 min read
Press Releases
LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC
June 27, 2025
·
4 min read
GLP-1
Prescription Drug Sales Will Hit $1.75T By 2030 Thanks to GLP-1s: Evaluate
Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be three times larger than what AbbVie’s blockbuster Humira ever achieved.
June 25, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Somatic Therapy Market to Reach USD 12.40 Billion by 2032 at 17.5% CAGR: Coherent Market Insights
July 1, 2025
·
1 min read
Press Releases
GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034
July 14, 2025
·
1 min read
Press Releases
PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
June 26, 2025
·
12 min read
Press Releases
Biosimilars Market Size Estimated to Reach USD 175.99 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
4C Medical Secures $175M Series D Preferred Stock Financing
March 5, 2025
·
3 min read
Press Releases
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
March 12, 2025
·
4 min read
Press Releases
Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis
May 5, 2025
·
6 min read
1 of 1,769
Next
